- Sanofi/Genzyme convince FDA to OK Lemtrada in MS
- Teva attempts laquinimod rescue with two new indications
- Biogen's Tecfidera makes European progress
- Scottish HTA nods through eight products
COMMENT Other Informa Comment
- INTERVIEW: Dr Reddy's CEO on the 'windshield and rear view mirror'
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding